SCHEMBL5535285

SCHEMBL5535285

NC(=O)c1cccc2c1NCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.50
AURKA O14965 1/20 0.47
PARP1 P09874 9/20 0.46
NNMT P40261 1/20 0.41
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SLC13A5 Q86YT5 1/20 0.39
MAPK8 P45983 1/20 0.39
CSNK1A1 P48729 1/20 0.39
LIMK1 P53667 1/20 0.39
MAP2K1 Q02750 1/20 0.39
PRKAA1 Q13131 1/20 0.39
DYRK1A Q13627 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3384120 0.90 AURKA (0.50) SRCAURKAPARP1NNMTALOX15
SCHEMBL1520555 0.85 SRC (0.51) SRCALOX15HSD17B10SLC13A5ADORA2A
SCHEMBL30647012 0.85 SRC (0.51) SRCALOX15HSD17B10SLC13A5ADORA2A
SCHEMBL3729724 0.83 SRC (0.50) SRCSLC13A5ADORA2AADORA1KDM4E
SCHEMBL10834538 0.83 SRC (0.47) SRCAURKAPARP1NNMTSLC13A5
SCHEMBL12618954 0.81 SRC (0.44) SRCAURKAPARP1NNMTSLC13A5
SCHEMBL12653261 0.81 SRC (0.44) SRCAURKAPARP1NNMTSLC13A5
SCHEMBL749668 0.80 SRC (0.47) SRCALOX15HSD17B10SLC13A5KDM4E
SCHEMBL9410317 0.80 SRC (0.47) SRCMAPK1SLC13A5ADORA2AADORA1
SCHEMBL13903229 0.80 SRC (0.47) SRCMAPK1SLC13A5ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609868-B1 TETRAHYDROQUINOLINE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS RAQUALIA PHARMA INC (JP) 2023-10-18 EP claimed
EP-3394068-A1 TDO2 INHIBITORS Genentech, Inc. (US) 2018-10-31 EP claimed
WO-2017107979-A1 TDO2 INHIBITORS GENENTECH, INC. (US) 2017-06-29 WO claimed
WO-2023237049-A1 DEGRADATION OF IRAK4 BY CONJUGATION OF IRAK4 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2023-12-14 WO disclosed
EP-3394068-A1 TDO2 INHIBITORS Genentech, Inc. (US) 2018-10-31 EP disclosed
WO-2017107979-A1 TDO2 INHIBITORS GENENTECH, INC. (US) 2017-06-29 WO disclosed
CN-104822653-B N-prop-2-ynylcarboxamide derivatives and their use as TRPA1 antagonists 奥赖恩公司 2017-03-08 CN disclosed
EP-1758865-A1 PYRIDINE ANALOGS AS C5A ANTAGONISTS Merck Frosst Canada Ltd. (CA) 2007-03-07 EP disclosed
WO-2005121095-A1 PYRIDINE ANALOGS AS C5A ANTAGONISTS MERCK FROSST CANADA LTD. (CA) 2005-12-22 WO disclosed